SCHEMBL2174499

SCHEMBL2174499

CCc1ccc(NC(=O)NCc2nc(C(=O)NCCc3ccccc3F)cs2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.49
SLC40A1 Q9NP59 2/20 0.47
IGF1R P08069 1/20 0.47
RAB9A P51151 4/20 0.46
HIF1A Q16665 5/20 0.45
GAA P10253 3/20 0.44
NPC1 O15118 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NAMPT P43490 1/20 0.43
MAPT P10636 5/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
LMNA P02545 5/20 0.43
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ALOX12 P18054 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4395207 0.88 CNR1 (0.51) CNR1SLC40A1IGF1RRAB9AHIF1A
SCHEMBL2172958 0.81 CNR1 (0.54) CNR1IGF1RRAB9AHIF1AGAA
SCHEMBL5669690 0.81 MAPT (0.65) RAB9AHIF1AGAANPC1NAMPT
SCHEMBL4384669 0.78 RAB9A (0.53) RAB9AGAANPC1L3MBTL1NAMPT
SCHEMBL5668071 0.78 IGF1R (0.48) SLC40A1IGF1RRAB9AHIF1ANPC1
SCHEMBL2172176 0.77 HDAC3 (0.51) SLC40A1IGF1RRAB9AHIF1ANPC1
SCHEMBL2187599 0.77 HIF1A (0.55) SLC40A1IGF1RRAB9AHIF1ANPC1
SCHEMBL5669757 0.76 IGF1R (0.53) SLC40A1IGF1RRAB9AHIF1ANPC1
SCHEMBL4550570 0.76 SLC40A1 (0.52) SLC40A1IGF1RRAB9AHIF1ANPC1
SCHEMBL5667924 0.73 SLC40A1 (0.46) SLC40A1IGF1RRAB9AHIF1ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973061-B2 Anaplastic lymphoma kinase modulators and methods of use EXELIXIS, INC. (US) 2011-07-05 US disclosed